Anastasios Stathis (@AnastasiosStat2) profile picture

Medical Oncologist. Head-Phase I Program, Oncology Institute of Southern Switzerland. Professor-Università della Svizzera Italiana.

Bellinzona, CH
Joined September 2017
Photo by Anastasios Stathis (@AnastasiosStat2)Photo by Anastasios Stathis (@AnastasiosStat2)
Anastasios Stathis retweeted
MDICT 2024 recommendations for neoadjuvant early clinical trials now published. Led by ESMO-TAT chairs @lillian_siu @ElenaGarralda @AnastasiosStat2 and MDICT’24 team supported by @myESMO sciencedirect.com/science/ar…
6
2
8
3,299
Anastasios Stathis retweeted
Great session this afternoon on #oncology #drug development 💉💊 #Biotech status & prospects Fruitful live discussion & interaction #ESMOTAT24 – at Paris, France
3
8
383
Anastasios Stathis retweeted
#ESMOTAT2023 starting. Amazing agenda and very excited to see so many attendees from all over the world in this important drug development meeting👏👏👏
4
29
1,383
Anastasios Stathis retweeted
ESMO announces Funda Meric-Bernstam as the recipient of 2024 TAT Honorary Award for her outstanding contributions to #PrecisionOncology. 📅 She will deliver her award lecture on 26 February at the #ESMOTAT24 in Paris 📌ow.ly/nTmE50QymhO.
6
23
3,205
Anastasios Stathis retweeted
#ESMOTAT24: Early registration deadline 📢⏲️ 10 January 2024 at 23:59 (CET). Watch @LSeymourMD, Shivaani Kummar, Irene Braña, Timothy Yap, @lillian_siu, @ElenaGarralda & @AnastasiosStat2 give their takes on why you should attend. 👇 ow.ly/8W3X50Qp5TU
5
8
2,476
Replying to @thanosplevris
Αραγε τι σημαια έχεις κρεμασμένη εσυ στο σπίτι σου κύριε (με ποια προσόντα;) πρώην υπουργέ υγείας;
22
Anastasios Stathis retweeted
#ESMOTAT24: Last few hours to make sure you are part of this international multi-stakeholder forum in the early drug development arena. ⏰Abstract submission deadline today (28/11, 21:00 CET) ow.ly/PSnM50QbS8G @lillian_siu @ElenaGarralda @AnastasiosStat2
1
6
9
2,786
Replying to @thanosplevris
Και μετά ήρθαν οι φίλοι σου οι ναζί
29
Anastasios Stathis retweeted
#ESMOTAT24: Be part of this international multi-stakeholder forum in the early drug development arena! Merit travel grants are available. ⏰Abstract submission deadline: 28 November 2023. ow.ly/HsQL50PR0G4 @lillian_siu @ElenaGarralda @AnastasiosStat2
10
21
4,743
Anastasios Stathis retweeted
#ESMOTAT24: Shape the future of cancer #drugdevelopment and take part in this unique forum gathering all relevant stakeholders in #oncology. ⏰Abstract submission deadline: 28 November 2023. ow.ly/HC3A50PLsEJ @lillian_siu @ElenaGarralda @AnastasiosStat2
3
13
3,655
Replying to @PrimeministerGR
Πόσοι άνθρωποι έχασαν την ζωή τους κ Πρωθυπουργέ;
1
3
500
Anastasios Stathis retweeted
#ESMOTAT24 taking place Feb 26-28, 2024, in Paris! Abstract submission now open till Nov 28, 2023: esmo.org/meeting-calendar/es… @myESMO New meeting features with parallel industry sessions - not to be missed
11
1
29
8,256
Replying to @Dora_Bakoyannis
Συγχαρητήρια, πολύ συγκινητικό. Καμία φωτια θα σβησετε;
2
80
Dall’EOC cinque nuovi Professori titolari per la Facoltà di scienze biomediche dell’USI. Comunicato stampa: eoc.ch/comunicazione/Comunic…
1
4
262
Replying to @thanosplevris
Ακόμα δεν έχω καταλάβει για ποιον λόγο είστε υπουργός υγείας στην Ελλάδα.
1
74
Replying to @thanosplevris
Το σύστημα υγείας στην Ελλάδα είναι κατεστραμμένο και έχετε τεράστια ευθύνη και εσείς και οι φίλοι σας διοικητές των νοσοκομείων (που γίνονται φυσικά διοικητές μόνο επειδή φίλοι σας)
34
📢🗓The #17ICML Scientific Program, based on more than 800 submitted abstracts, is almost ready! Watch the video to have a sneak peek of the 17-ICML and stay tuned!
5
16
3,243
Replying to @MakisVoridis
Και καλή λευτεριά σύντομα από την φασιστική σας κυβέρνηση
31
Anastasios Stathis retweeted
The abstract of the other one of our two #AACR23 #lymphoma posters. @IOR_Bellinzona @USI_en @EnteOspedaliero @CascioneLuciano @AnastasiosStat2 @SpexisAg Adding CXCR4 inhibition to improve activity of anti-lymphoma agents: abstractsonline.com/pp8/#!/1…
2
3
457
Anastasios Stathis retweeted
The abstract of one of our two #AACR23 #lymphoma posters. @IOR_Bellinzona @USI_en @EnteOspedaliero @CascioneLuciano @AnastasiosStat2 @ManelEsteller ERBB4 as resistance to BTK and PI3K inhibitors in lymphomas: abstractsonline.com/pp8/#!/1…
1
6
436